The patients experienced the drug-induced liver diseases in 2~4 weeks and within 2 weeks after the administration of drugs(66% vs.26.2%). The most diagnoses of the liver diseases included acute hepatocellular hepatitis(62.1%) and jaundice(59.2%).
The patients experienced the drug-induced liver diseases in 2~4 weeks and within 2 weeks after the administration of drugs(66% vs.26.2%). The most diagnoses of the liver diseases included acute hepatocellular hepatitis(62.1%) and jaundice(59.2%).
用药2~4周出现肝损害者最常见(66%),2周内者次之(26.2%),临床以急性肝炎肝细胞型最常见(62.1%),其中5例出现暴发性肝功能衰竭(4.9%);